新型冠状病毒肺炎中的单核细胞和树突状细胞缺陷 - Suppr

Suppr

超能文献

Monocyte and dendritic cell defects in COVID-19.

作者信息

Wack Andreas

机构信息

Immunoregulation Laboratory, Francis Crick Institute, London, UK.

出版信息

Nat Cell Biol. 2021 May;23(5):445-447. doi: 10.1038/s41556-021-00685-y.

DOI:10.1038/s41556-021-00685-y

PMID:33972732

Abstract

摘要

相似文献

Monocyte and dendritic cell defects in COVID-19.新型冠状病毒肺炎中的单核细胞和树突状细胞缺陷

Nat Cell Biol. 2021 May;23(5):445-447. doi: 10.1038/s41556-021-00685-y.

Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19.COVID-19 住院后超过 6 个月，单核细胞和树突状细胞亚群发生重大改变。

Front Immunol. 2023 Jan 4;13:1082912. doi: 10.3389/fimmu.2022.1082912. eCollection 2022.

Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.COVID-19 中的呼吸和全身单核细胞、树突状细胞和髓系来源的抑制性细胞：对疾病严重程度的影响。

J Intern Med. 2023 Feb;293(2):130-143. doi: 10.1111/joim.13559. Epub 2022 Aug 31.

Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccination.轻度新冠肺炎患者及黄热病疫苗接种后循环树突状细胞和单核细胞的独特动态激活谱。

Eur J Immunol. 2023 Mar;53(3):e2250090. doi: 10.1002/eji.202250090. Epub 2022 Dec 9.

Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.COVID-19 免疫发病机制中的树突状细胞：对其在决定疾病结局中可能起作用的深入了解。

Int Rev Immunol. 2021;40(1-2):108-125. doi: 10.1080/08830185.2020.1844195. Epub 2020 Nov 16.

CCR2 Signaling Restricts SARS-CoV-2 Infection.CCR2 信号限制 SARS-CoV-2 感染。

mBio. 2021 Dec 21;12(6):e0274921. doi: 10.1128/mBio.02749-21. Epub 2021 Nov 9.

SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.SARS-CoV-2 感染诱导循环单核细胞中 M1/M2 表型混合，并改变树突状细胞和单核细胞亚群。

PLoS One. 2020 Dec 31;15(12):e0241097. doi: 10.1371/journal.pone.0241097. eCollection 2020.

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.严重 COVID-19 肺炎患者的 sCD163 和 sCD14 血浆水平升高及外周血促炎单核细胞、髓系和浆细胞样树突状细胞耗竭。

Front Immunol. 2021 Feb 26;12:627548. doi: 10.3389/fimmu.2021.627548. eCollection 2021.

Plasmacytoid dendritic cells during COVID-19: Ally or adversary?COVID-19 期间的浆细胞样树突状细胞：盟友还是敌人？

Cell Rep. 2022 Jul 26;40(4):111148. doi: 10.1016/j.celrep.2022.111148. Epub 2022 Jul 14.

Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.新冠肺炎康复个体中循环单核细胞升高和单核细胞活化。

Front Immunol. 2023 Apr 3;14:1151780. doi: 10.3389/fimmu.2023.1151780. eCollection 2023.

引用本文的文献

Single-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases.单细胞多基因风险评分剖析复杂人类疾病的细胞和分子异质性。

Nat Biotechnol. 2025 Jul 25. doi: 10.1038/s41587-025-02725-6.

Single-cell sequencing of peripheral blood mononuclear cells reveals immune landscape of monkeypox patients with HIV.外周血单个核细胞的单细胞测序揭示了合并HIV的猴痘患者的免疫图谱。

Emerg Microbes Infect. 2025 Dec;14(1):2459136. doi: 10.1080/22221751.2025.2459136. Epub 2025 Feb 7.

Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.SARS-CoV-2 感染后 24 个月个体的长新冠免疫失调改善。

Nat Commun. 2024 Apr 17;15(1):3315. doi: 10.1038/s41467-024-47720-8.

Single-Cell RNA Sequencing Reveals HIF1A as a Severity-Sensitive Immunological Scar in Circulating Monocytes of Convalescent Comorbidity-Free COVID-19 Patients.单细胞 RNA 测序揭示 HIF1A 作为无合并症 COVID-19 患者恢复期循环单核细胞中严重程度敏感的免疫性瘢痕。

Cells. 2024 Feb 6;13(4):300. doi: 10.3390/cells13040300.

Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity.纵向单细胞图谱鉴定 I 型干扰素反应与 COVID-19 严重程度之间的复杂时间关系。

Nat Commun. 2024 Jan 18;15(1):567. doi: 10.1038/s41467-023-44524-0.

In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting.体内抑制核 ACE2 易位通过表观遗传印迹防止 SARS-CoV-2 复制和肺损伤。

Nat Commun. 2023 Jun 27;14(1):3680. doi: 10.1038/s41467-023-39341-4.

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms.新型冠状病毒2019感染期间的固有免疫和适应性免疫：生物分子细胞标志物与机制

Vaccines (Basel). 2023 Feb 10;11(2):408. doi: 10.3390/vaccines11020408.

Immune responses in mildly versus critically ill COVID-19 patients.轻症与重症 COVID-19 患者的免疫反应。

Front Immunol. 2023 Jan 30;14:1077236. doi: 10.3389/fimmu.2023.1077236. eCollection 2023.

Cellular immune states in SARS-CoV-2-induced disease.SARS-CoV-2 诱导疾病中的细胞免疫状态。

Front Immunol. 2022 Nov 23;13:1016304. doi: 10.3389/fimmu.2022.1016304. eCollection 2022.

Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C-C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections.鼻咽拭子标本中髓过氧化物酶（MPO）、腺苷脱氨酶（ADA）、C 型趋化因子配体 22（CCL22）、肿瘤坏死因子-α（TNFα）和白细胞介素-6（IL-6）mRNA 表达与 SARS-CoV-2 感染的诊断和严重程度的相关性。

Emerg Microbes Infect. 2023 Dec;12(1):2157338. doi: 10.1080/22221751.2022.2157338.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验